Follow
Wouter Ouwerkerk
Wouter Ouwerkerk
Unknown affiliation
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
W Ouwerkerk, AA Voors, SD Anker, JG Cleland, K Dickstein, G Filippatos, ...
European heart journal 38 (24), 1883-1890, 2017
3162017
Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure
W Ouwerkerk, AA Voors, AH Zwinderman
JACC: Heart Failure 2 (5), 429-436, 2014
3102014
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
AA Voors, W Ouwerkerk, F Zannad, DJ van Veldhuisen, NJ Samani, ...
European journal of heart failure 19 (5), 627-634, 2017
1942017
Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction
J Tromp, BD Westenbrink, W Ouwerkerk, DJ van Veldhuisen, NJ Samani, ...
Journal of the American College of Cardiology 72 (10), 1081-1090, 2018
1722018
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
BT Santema, W Ouwerkerk, J Tromp, IE Sama, A Ravera, ...
The Lancet 394 (10205), 1254-1263, 2019
1372019
The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
G Markousis‐Mavrogenis, J Tromp, W Ouwerkerk, M Devalaraja, ...
European journal of heart failure 21 (8), 965-973, 2019
1362019
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
TK Teng, J Tromp, WT Tay, I Anand, W Ouwerkerk, V Chopra, GS Wander, ...
Lancet Glob Health 6, e1008-e1018, 2018
104*2018
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
J Tromp, WT Tay, W Ouwerkerk, THK Teng, J Yap, MR MacDonald, ...
PLoS medicine 15 (3), e1002541, 2018
1032018
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
J Tromp, S Bamadhaj, JGF Cleland, CE Angermann, U Dahlstrom, ...
The Lancet Global Health 8 (3), e411-e422, 2020
802020
Microvascular disease in patients with diabetes with heart failure and reduced ejection versus preserved ejection fraction
J Tromp, SL Lim, WT Tay, THK Teng, C Chandramouli, W Ouwerkerk, ...
Diabetes Care 42 (9), 1792-1799, 2019
532019
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
JM Ter Maaten, AA Voors, K Damman, P van der Meer, SD Anker, ...
International journal of cardiology 253, 84-90, 2018
502018
A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction
J Tromp, W Ouwerkerk, DJ van Veldhuisen, HL Hillege, AM Richards, ...
Heart Failure 10 (2), 73-84, 2022
462022
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment
JF Nauta, YM Hummel, J Tromp, W Ouwerkerk, P van der Meer, X Jin, ...
European journal of heart failure 22 (7), 1147-1155, 2020
432020
Novel endotypes in heart failure: effects on guideline-directed medical therapy
J Tromp, W Ouwerkerk, BG Demissei, SD Anker, JG Cleland, K Dickstein, ...
European Heart Journal 39 (48), 4269-4276, 2018
392018
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
RJ Woolley, D Ceelen, W Ouwerkerk, J Tromp, SM Figarska, SD Anker, ...
European journal of heart failure 23 (6), 983-991, 2021
382021
Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF
W Ouwerkerk, AH Zwinderman, LL Ng, B Demissei, HL Hillege, F Zannad, ...
Journal of the American College of Cardiology 71 (4), 386-398, 2018
342018
Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality
JC Beusekamp, J Tromp, JGF Cleland, MM Givertz, M Metra, ...
JACC: Heart Failure 7 (11), 970-979, 2019
322019
Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review
W Ouwerkerk, M van den Berg, S van der Niet, J Limpens, RM Luiten
Melanoma research 29 (5), 453, 2019
222019
Distinct pathological pathways in patients with heart failure and diabetes
J Tromp, AA Voors, A Sharma, JP Ferreira, W Ouwerkerk, HL Hillege, ...
Heart Failure 8 (3), 234-242, 2020
212020
Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT …
W Ouwerkerk, THK Teng, J Tromp, WT Tay, JG Cleland, ...
European Journal of Heart Failure 22 (8), 1472-1482, 2020
192020
The system can't perform the operation now. Try again later.
Articles 1–20